The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,4S,5S,7S)-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-amino-N-butyl-4-hydroxy-2,8-dimethylnonanamide hydrochloride ID: ALA557193
PubChem CID: 23625952
Max Phase: Preclinical
Molecular Formula: C27H49ClN2O5
Molecular Weight: 480.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H](N)C[C@H](Cc1ccc(OC)c(OCCCOC)c1)C(C)C.Cl
Standard InChI: InChI=1S/C27H48N2O5.ClH/c1-7-8-12-29-27(31)20(4)15-24(30)23(28)18-22(19(2)3)16-21-10-11-25(33-6)26(17-21)34-14-9-13-32-5;/h10-11,17,19-20,22-24,30H,7-9,12-16,18,28H2,1-6H3,(H,29,31);1H/t20-,22+,23+,24+;/m1./s1
Standard InChI Key: DJSOHWCDIVRKMG-QFUPZHBKSA-N
Molfile:
RDKit 2D
35 34 0 0 0 0 0 0 0 0999 V2000
7.6894 -6.0113 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2296 -5.4127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1872 -7.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4854 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4833 -9.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7815 -10.5188 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4430 -10.3638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.7793 -12.0196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0775 -12.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0754 -14.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1134 -14.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8509 -5.8560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2956 -3.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2952 -4.9547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2564 -3.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5257 -7.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5955 2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1877 -7.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 7 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 6
12 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
11 23 1 6
9 24 1 6
24 25 1 0
24 26 1 0
2 27 1 0
27 28 1 0
15 29 1 6
3 30 1 0
30 31 1 0
28 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 480.69Molecular Weight (Monoisotopic): 480.3563AlogP: 3.95#Rotatable Bonds: 18Polar Surface Area: 103.04Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.57CX LogP: 3.71CX LogD: 1.59Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: 0.22
References 1. Göschke R, Stutz S, Rasetti V, Cohen NC, Rahuel J, Rigollier P, Baum HP, Forgiarini P, Schnell CR, Wagner T, Gruetter MG, Fuhrer W, Schilling W, Cumin F, Wood JM, Maibaum J.. (2007) Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin., 50 (20): [PMID:17824679 ] [10.1021/jm070314y ] 2. Maibaum J, Stutz S, Göschke R, Rigollier P, Yamaguchi Y, Cumin F, Rahuel J, Baum HP, Cohen NC, Schnell CR, Fuhrer W, Gruetter MG, Schilling W, Wood JM.. (2007) Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets., 50 (20): [PMID:17824680 ] [10.1021/jm070316i ]